06
Jan

Cardio3 BioSciences is buying the cancer division of Celdara Medical, trading $10 million up front and promising more in exchange for a seat at the immuno-oncology table.

…read more

Source: Cardio3 dives into CAR-T with $180M Celdara deal

    

0 No comments